InsidersTradesSigma
Explore the complete record of transactions filed by Megna Michael R, Directeur Comptable. Insider active across 1 company, notably Kiniksa Pharmaceuticals, Ltd.. In total, 2 reports have been published. History available since 30 June 2020. The latest transaction was disclosed on 30 June 2020 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
2 of 2 declarations
Michael R. Megna is the Chief Accounting Officer at Kiniksa Pharmaceuticals, Ltd. He is responsible for managing accounting operations and financial compliance. Megna leverages his expertise to ensure the integrity of the company's financial reporting.